GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,666 | -31.1% | 2,814,191 | 0.0% | 0.46% | -4.8% |
| Q2 2023 | $15,478 | +27.9% | 2,814,191 | 0.0% | 0.48% | -33.2% |
| Q1 2023 | $12,101 | +9.4% | 2,814,191 | 0.0% | 0.72% | +16.5% |
| Q4 2022 | $11,060 | -99.9% | 2,814,191 | 0.0% | 0.62% | -3.3% |
| Q3 2022 | $14,943,000 | -19.1% | 2,814,191 | 0.0% | 0.64% | -35.3% |
| Q2 2022 | $18,461,000 | -10.6% | 2,814,191 | 0.0% | 0.99% | +14.0% |
| Q1 2022 | $20,656,000 | +3.7% | 2,814,191 | 0.0% | 0.86% | +59.9% |
| Q4 2021 | $19,924,000 | -71.8% | 2,814,191 | 0.0% | 0.54% | -65.7% |
| Q3 2021 | $70,552,000 | -6.8% | 2,814,191 | 0.0% | 1.58% | +2.8% |
| Q2 2021 | $75,702,000 | -5.5% | 2,814,191 | 0.0% | 1.54% | +8.6% |
| Q1 2021 | $80,092,000 | +0.4% | 2,814,191 | 0.0% | 1.42% | -17.4% |
| Q4 2020 | $79,782,000 | -8.3% | 2,814,191 | 0.0% | 1.71% | -18.9% |
| Q3 2020 | $86,987,000 | +47.2% | 2,814,191 | 0.0% | 2.11% | +27.7% |
| Q2 2020 | $59,098,000 | – | 2,814,191 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $31,379,244 | 4.86% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $3,875,415 | 0.71% |
| Artal Group S.A. | 2,814,191 | $10,666 | 0.46% |
| PFM Health Sciences, LP | 2,514,443 | $9,529,739 | 0.45% |
| Yiheng Capital Management, L.P. | 1,666,181 | $6,314,826 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 356,740 | $1,352,045 | 0.26% |
| EcoR1 Capital, LLC | 2,046,867 | $7,757,626 | 0.26% |
| Bellevue Group AG | 3,617,080 | $13,708,733 | 0.22% |
| SVB FINANCIAL GROUP | 25,034 | $94,879 | 0.18% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,681 | $142,811 | 0.03% |